Reaction Details |
| Report a problem with these data |
Target | Neuromedin-K receptor |
---|
Ligand | BDBM430824 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | 3H-SB222200 Binding Competition Assay with Human NK-3 Receptor |
---|
Ki | <500±n/a nM |
---|
Citation | Hoveyda, HR; Roy, M; Fraser, GL; Dutheuil, G NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders US Patent US10544150 Publication Date 1/28/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuromedin-K receptor |
---|
Name: | Neuromedin-K receptor |
Synonyms: | NK-3 receptor | NK-3R | NK3R | NK3R_HUMAN | NKR | Neurokinin 3 receptor | Neurokinin B receptor | Neurokinin-3 (NK-3) | Neuromedin-3 receptor (NK-3R) | Neuromedin-3 receptor (NK3) | Neuromedin-K receptor | Neuromedin-K receptor (NK-3 receptor) | Neuromedin-K receptor (NK3) | Neuromedin-K receptor(NK3R) | TAC3R | TACR3 | Tachykinin receptor 3 | Tachykinin receptor 3 (NK3) |
Type: | Enzyme |
Mol. Mass.: | 52221.96 |
Organism: | Homo sapiens (Human) |
Description: | P29371 |
Residue: | 465 |
Sequence: | MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGL
PVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVT
NYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIA
VDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEG
PKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKM
MIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLN
KRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADT
TRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
|
|
|
BDBM430824 |
---|
n/a |
---|
Name | BDBM430824 |
Synonyms: | (4-fluorophenyl)(3-(2-(pyrrolidin-1-yl)thiazol-4-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone | US10544150, Compound 249 |
Type | Small organic molecule |
Emp. Form. | C19H19FN6OS |
Mol. Mass. | 398.457 |
SMILES | Fc1ccc(cc1)C(=O)N1CCn2c(C1)nnc2-c1csc(n1)N1CCCC1 |
Structure |
|